Fulgent Genetics (FLGT) Gross Profit (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Gross Profit data on file, last reported at $21.5 million in Q1 2026.

• Quarterly Gross Profit fell 24.19% year-over-year to $21.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $124.0 million (up 9.31% YoY) and the FY2025 annual result came in at $130.9 million, up 22.07% from the prior year.
• Gross Profit fell to $21.5 million in Q1 2026 per FLGT's latest filing, from $32.6 million in the prior quarter.
• The five-year high for Gross Profit was $242.5 million in Q1 2022, with the low at $13.0 million in Q4 2022.
• Average Gross Profit over 5 years is $43.0 million, with a median of $28.3 million recorded in 2025.
• Year-over-year, Gross Profit sank 93.15% in 2022 and soared 94.26% in 2023.
• Fulgent Genetics' Gross Profit stood at $13.0 million in 2022, then soared by 94.26% to $25.2 million in 2023, then gained by 26.24% to $31.8 million in 2024, then rose by 2.3% to $32.6 million in 2025, then sank by 34.04% to $21.5 million in 2026.
• Business Quant data shows FLGT's Gross Profit at $21.5 million in Q1 2026, $32.6 million in Q4 2025, and $35.5 million in Q3 2025.